Arthur M. Cohen & Associates, LLC Bristol Myers Squibb CO Transaction History

Arthur M. Cohen & Associates, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 22, 2024	BUY	$47.98 - $54.4 $191,440 - $217,056	3,990 New	3,990 $216,000
Q4 2019 Jan 10, 2020	SELL	$49.21 - $64.19 $196,347 - $256,118	-3,990 Closed	0 $0
Q3 2019 Nov 04, 2019	BUY	$42.77 - $50.71 $170,652 - $202,332	3,990 New	3,990 $202,000
Q2 2019 Jul 29, 2019	SELL	$44.62 - $49.34 $390,201 - $431,478	-8,745 Closed	0 $0
Q1 2019 May 07, 2019	SELL	$45.12 - $53.8 $1.77 Million - $2.11 Million	-39,191 Reduced 81.76%	8,745 $417,000
Q3 2018 Oct 22, 2018	SELL	$55.19 - $62.25 $194,875 - $219,804	-3,531 Reduced 6.86%	47,936 $2.98 Million
Q2 2018 Aug 13, 2018	BUY	$50.53 - $62.98 $7,074 - $8,817	140 Added 0.27%	51,467 $2.85 Million
Q1 2018 Apr 23, 2018	BUY	$59.92 - $68.98 $1.27 Million - $1.47 Million	21,273 Added 70.78%	51,327 $3.15 Million
Q4 2017 Mar 06, 2019	SELL	$59.94 - $65.35 $1.47 Million - $1.6 Million	-24,443 Reduced 44.85%	30,054 $1.56 Million
Q4 2017 Jan 26, 2018	SELL	$59.94 - $65.35 $113,886 - $124,164	-1,900 Reduced 3.37%	54,497 $3.34 Million
Q3 2014 Nov 08, 2017	BUY	N/A	56,397	56,397 $3.6 Million

2,425

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Arthur M. Cohen & Associates, LLC, based on Form 13F filings with the SEC.

Stay updated on Arthur M. Cohen & Associates, LLC with notifications on news.